Coherus BioSciences, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.020
+0.051 (5.30%)
At close: May 12, 2025, 4:00 PM
0.8199
-0.2000 (-19.62%)
After-hours: May 12, 2025, 7:59 PM EDT

Coherus BioSciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-130.9428.51-237.89-291.75-287.1132.24
Upgrade
Depreciation & Amortization
5.285.283.793.73.452.89
Upgrade
Other Amortization
4.164.162.416.434.263.48
Upgrade
Loss (Gain) From Sale of Assets
-176.59-176.59----
Upgrade
Asset Writedown & Restructuring Costs
10.5710.57--3.21-
Upgrade
Loss (Gain) From Sale of Investments
----1.1-
Upgrade
Stock-Based Compensation
27.827.843.1150.7451.3638.16
Upgrade
Other Operating Activities
204.3223.9450.5369.02143.9312.02
Upgrade
Change in Accounts Receivable
149.35149.35-150.6813.0534.06-15.22
Upgrade
Change in Inventory
-31.95-31.95-46.73-47.35-6.25-38.36
Upgrade
Change in Accounts Payable
-3.94-3.9423.76-4.550.87-9.82
Upgrade
Change in Other Net Operating Assets
-57.57-57.57136.83-40.4113.6828.75
Upgrade
Operating Cash Flow
0.5-20.44-174.88-241.12-37.43154.15
Upgrade
Operating Cash Flow Growth
-----443.63%
Upgrade
Capital Expenditures
-192.54----1.29-7.23
Upgrade
Sale of Property, Plant & Equipment
-----0.18
Upgrade
Cash Acquisitions
--7---
Upgrade
Divestitures
227.82227.82----
Upgrade
Sale (Purchase) of Intangibles
-25-12.5--35--7.5
Upgrade
Investment in Securities
-14.89138.14-127.38-1.120.16
Upgrade
Other Investing Activities
-0.210.11-0.49-4.47-136-
Upgrade
Investing Cash Flow
10.07230.32144.64-166.85-138.41-14.4
Upgrade
Long-Term Debt Issued
-36.98-240.68-222.16
Upgrade
Long-Term Debt Repaid
--260.39--190.75--
Upgrade
Net Debt Issued (Repaid)
-223.41-223.41-49.93-222.16
Upgrade
Issuance of Common Stock
1.172.6774.229.3754.321.23
Upgrade
Repurchase of Common Stock
-2-2.48-3.59-3.74-1.75-0.88
Upgrade
Other Financing Activities
36.1136.24-1.03-1.23-0.67-18.56
Upgrade
Financing Cash Flow
-188.13-186.9769.654.3351.88223.95
Upgrade
Net Cash Flow
-177.5522.9139.36-353.65-123.96363.69
Upgrade
Free Cash Flow
-192.04-20.44-174.88-241.12-38.72146.91
Upgrade
Free Cash Flow Growth
-----453.70%
Upgrade
Free Cash Flow Margin
-70.54%-7.66%-67.98%-114.25%-11.86%30.88%
Upgrade
Free Cash Flow Per Share
-1.67-0.18-1.86-3.11-0.511.76
Upgrade
Cash Interest Paid
25.3825.3837.8634.8818.6816.96
Upgrade
Cash Income Tax Paid
--0.11-0.120.041.223.95
Upgrade
Levered Free Cash Flow
-292.5341.59-69.86-186.86-60.9783.04
Upgrade
Unlevered Free Cash Flow
-280.3254.4-46.93-173-50.8892.78
Upgrade
Change in Net Working Capital
50.85-92.8-26.9231.88-60.5131.23
Upgrade
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q